Llwytho...
IMMU-14. TARGETING CD200 ACTIVATION RECEPTORS TO OVERCOME THE IMMUNOSUPPRESSIVE TUMOR MICROENVIRONMENT
Glioblastoma multiforme is an incurable primary brain tumor. The current standard of care consists of resection followed by radiation and chemotherapy; associated with a median overall survival of 14.6 months. To overcome this dismal outcome, clinicians are turning to immunotherapeutic approaches, w...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Neuro Oncol |
|---|---|
| Prif Awduron: | , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Oxford University Press
2017
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5692474/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.473 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|